Hematopoietic Stem Cell TransplantationPeripheral Blood Stem Cell TransplantationTransplantation, HomologousStem Cell TransplantationTransplantation, AutologousTransplantation ConditioningGraft vs Host DiseaseHematopoietic Stem Cell MobilizationHematopoietic Stem CellsStem CellsHematologic NeoplasmsGraft SurvivalBone Marrow TransplantationTransplantation ChimeraGranulocyte Colony-Stimulating FactorLeukapheresisBusulfanAntigens, CD34Myeloablative AgonistsTreatment OutcomeTissue DonorsCord Blood Stem Cell TransplantationCombined Modality TherapyMelphalanBlood Component RemovalRecurrenceRemission InductionMultiple MyelomaVidarabineGraft vs Leukemia EffectCyclophosphamideWhole-Body IrradiationHistocompatibility TestingAntineoplastic Combined Chemotherapy ProtocolsGraft vs Tumor EffectRadiationLeukemiaImmunosuppressive AgentsHistocompatibilityLeukemia, Myeloid, AcuteRetrospective StudiesMice, SCIDDisease-Free SurvivalLymphocyte TransfusionSalvage TherapyLymphocyte DepletionFlow CytometryLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCytomegalovirus InfectionsSurvival RateSurvival AnalysisTime FactorsSiblingsLymphoma, Non-HodgkinTransplantation, HeterologousMyelodysplastic SyndromesMesenchymal Stem Cell TransplantationNeoplasm, ResidualEmbryonic Stem CellsHematopoiesisT-LymphocytesEtoposideAntilymphocyte SerumPrecursor Cell Lymphoblastic Leukemia-LymphomaChimerismMice, Inbred NODBlood CellsAnemia, AplasticAdult Stem CellsCytarabineBone Marrow CellsBlood Cell CountInfectionHematologic DiseasesCell DifferentiationBone MarrowMinor Histocompatibility AntigensHodgkin DiseaseAcute DiseaseThiotepaAntineoplastic Agents, AlkylatingMice, Inbred C57BLVirus ActivationTransplantation, IsogeneicFollow-Up StudiesHLA AntigensCell TransplantationBlood DonorsLiver TransplantationCytomegalovirusTransplantation ImmunologyCells, CulturedPluripotent Stem CellsImmunosuppressionLeukocyte TransfusionFetal BloodHepatic Veno-Occlusive DiseaseNuclear FamilyImmunophenotypingMesenchymal Stromal Cells